Dr. Cheryl Li has been appointed senior vice president of Global CMC Services, Frontage Laboratories. The CMC Services division offers Dosage Form product development, contract manufacturing, pharmaceutical analysis, organic syntheses, as well as strategy consulting. Dr. Li’s position is an initial step in strategic expansion efforts for the CMC infrastructure.
 
Prior to joining the company, Dr. Li held several management positions at Johnson and Johnson Consumer Group companies. Most recently, she was director of Global Innovation Sourcing and Strategic Partnership, where she led growth initiatives involving product and process technologies for OTC , health and nutrition, skin, oral and personal care businesses. Previously, she was director, strategic sourcing/external technology and supply. Earlier, she served as director of technical operations at Mallinckrodt Baker/Covidien and led product development groups at Albany Molecular Research Inc. and Honeywell.
 
“Cheryl Li brings an impressive tenure of designing and leading successful growth and innovation strategies for organizations of different sizes across biopharmaceuticals, consumer healthcare and consumer product industries through deploying a balanced approach using strategic partnerships, licensing and acquisitions and internal innovation execution,” said Dr. Song Li, chairman and chief executive officer. “I’m confident that Frontage will significantly benefit from her broad technical knowledge, global industry network, and business experience driving strong collaborations as the company enters its next phase of growth.”